Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network.
Saved in:
| Title: | Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network. |
|---|---|
| Authors: | Bastos-Oreiro M; Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón Madrid Spain., Iacoboni G; Hematology Department, University Hospital Vall d'Hebron Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Navarro V; Statistics Unit Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Martínez C; Institut Catalá d'Oncologia Hospitalet, IDIBELL Universitat de Barcelona Barcelona Spain., Manresa P; Hospital General de Alicante Alicante Spain., Magnano L; Hospital Clínic Barcelona Spain., Jiménez-Ubieto A; Hospital 12 de Octubre Madrid Spain., Vázquez S; Hematology Department Hospital Juan Ramón Jiménez Huelva Spain., Rodriguez MJ; Hospital Insultar de Tenerife Islas Canarias Spain., Busnego MT; Hospital Universitario Nuestra Señora de la Candelaria Tenerife Spain., Del Campo R; Hospital Son Llatzer Mallorca Spain., Paúl PJ; Hospital Universitario Lozano Blesa Zaragoza Spain., Murillo I; Hospital Miguel Servet Zaragoza Spain., Donato EM; Hospital Universitario Doctor Peset Valencia Spain., Serna A; Hematology Department, University Hospital Vall d'Hebron Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Luzardo H; Hospital Universitario Dr Negrin Gran Canaria Spain., Gómez P; Hospital Universitario La Paz Madrid Spain., Pérez E; Hospital General Universitario Morales Meseguer Murcia Spain., Mendibil B; Hospital Universitario de Donostia País Vasco Spain., Ramos S; Fundacion Jimenez Diaz Madrid Spain., García-Noblejas A; Hospital Universitario de La PrIncesa Madrid Spain., Gonzalez de Villambrosia S; Hospital Universitario Marqués de Valcedillas Santander Spain., Díaz FJ; Hospital Universitario de Burgos Burgos Spain., López J; Hospital Universitario Ramón y Cajal Madrid Spain., Martín-Moro F; Hospital Universitario Ramón y Cajal Madrid Spain., Fernandez-Caldas P; Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón Madrid Spain., Fernandez R; Hospital Universitario de Cabueñes Gijón Spain., Gutierrez A; Hospital Son Espases Palma de Mallorca Spain., Sánchez B; Hospital del Mar Barcelona Spain., Domínguez N; Hospital Universitario Virgen de la Macarena Sevilla Spain., Civeira M; Hospital Royo Villanova Zaragoza Spain., Villafuerte P; Hospital Príncipe de Asturias Madrid Spain., Olazabal I; Hospital Universitario de Donostia País Vasco Spain., Zeberio I; Hospital Universitario de Donostia País Vasco Spain., Barrenetxea C; Hospital Universitario Basurto Bilbao Spain., Gutierrez N; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain., Romero S; Hospital Universitario La Fe de Valencia València Spain., Martín-Consuegra S; Hospital Comarcal Alcañiz Teruel Spain., Huerga S; Clínica Universitaria de Navarra Pamplona Spain., Golbano N; Hospital Universitario de Guadalajara Guadalajara Spain., Riaza R; Hospital Universitario Severo Ochoa de Leganes Madrid Spain., Hueso JA; Hospital Universitario de La Plana Castellón Spain., Martinez-Barranco P; Hospital Universitario Fundación Alcorcón Madrid Spain., Navarro B; Hospital Universitario Puerta de Hierro Madrid Spain., Villalón L; Hospital Universitario Fundación Alcorcón Madrid Spain., Ortega P; Complejo Hospitalario Insular Gran Canaria Spain., Torres A; Hospital Universitario de Segovia Segovia Spain., Ormenazabal I; Hospital Universitario de Navarra Navarra Spain., Sanchez Anton MP; Hospital Universitario de Navarra Navarra Spain., Goñi MA; Hospital Universitario de Navarra Navarra Spain., Abrisqueta P; Hematology Department, University Hospital Vall d'Hebron Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Martín García-Sancho A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain. |
| Source: | HemaSphere [Hemasphere] 2026 Jun 16; Vol. 10 (6), pp. e70398. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026). |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70398 |
